Dishman Carbogen Amcis Ltd

Dishman Carbogen Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dishman Carbogen Amcis Ltd

₹ 269 0.48%
27 Dec - close price
dishmangroup.com BSE: 540701 NSE: DCAL
About

Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.[1]

Key Points

Business Segments & Revenue Contribution

Website BSE NSE
  • Market Cap ₹ 4,220 Cr.
  • Current Price ₹ 269
  • High / Low ₹ 308 / 133
  • Stock P/E
  • Book Value ₹ 258
  • Dividend Yield 0.00 %
  • ROCE -0.73 %
  • ROE -1.84 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Stock is trading at 1.04 times its book value

Cons

  • Company has low interest coverage ratio.
  • Company has a low return on equity of -1.28% over last 3 years.
  • Earnings include an other income of Rs.45.4 Cr.
  • Company has high debtors of 205 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of Nifty Total Market Nifty Microcap 250 BSE Allcap BSE Healthcare BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
84 74 84 104 107 78 113 70 60 87 111 103 93
58 69 81 101 105 82 107 75 63 84 100 89 80
Operating Profit 26 5 3 3 1 -3 6 -5 -3 3 12 15 13
OPM % 31% 6% 4% 3% 1% -4% 6% -7% -5% 4% 10% 14% 14%
13 16 8 4 21 10 15 14 36 13 -3 12 24
Interest 8 11 10 13 14 15 17 18 17 17 16 16 16
Depreciation 35 35 34 35 35 3 23 25 25 26 26 16 16
Profit before tax -5 -26 -33 -40 -27 -10 -19 -33 -9 -27 -34 -6 5
Tax % -38% -23% -114% -37% -36% -37% -47% -35% -38% -33% -7% -38% -162%
-3 -20 5 -25 -17 -7 -10 -21 -6 -18 -31 -3 14
EPS in Rs -0.18 -1.25 0.31 -1.58 -1.10 -0.42 -0.65 -1.36 -0.37 -1.16 -1.98 -0.22 0.91
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
0 7 451 474 549 581 200 307 403 327 395
0 5 303 308 356 401 253 267 394 321 352
Operating Profit -0 2 148 166 194 179 -53 40 9 7 43
OPM % 25% 33% 35% 35% 31% -26% 13% 2% 2% 11%
0 0 71 66 72 64 59 53 49 60 45
Interest 1 1 39 35 47 47 34 37 58 68 64
Depreciation 0 0 136 134 136 141 141 140 96 102 85
Profit before tax -0 1 44 62 82 55 -169 -84 -96 -103 -61
Tax % 0% 12% 45% 40% 31% 31% 38% -63% -39% -26%
-0 1 24 37 56 39 -233 -32 -59 -76 -39
EPS in Rs 2.30 3.47 2.46 -14.85 -2.01 -3.75 -4.87 -2.45
Dividend Payout % 0% 0% 0% 0% 6% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: -10%
3 Years: 18%
TTM: 23%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 19%
TTM: 1%
Stock Price CAGR
10 Years: %
5 Years: 27%
3 Years: 11%
1 Year: 52%
Return on Equity
10 Years: %
5 Years: -2%
3 Years: -1%
Last Year: -2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.05 0.05 0.00 32 32 31 31 31 31 31 31
Reserves -1 0 4,771 4,759 4,860 4,764 4,643 4,200 4,083 4,021 4,014
10 9 445 622 584 573 538 535 593 536 605
3 3 321 394 339 366 339 448 473 488 457
Total Liabilities 12 12 5,537 5,807 5,816 5,735 5,552 5,214 5,181 5,077 5,108
0 0 1,927 1,853 1,715 1,633 1,510 1,356 1,382 1,416 1,388
CWIP 0 0 41 48 70 89 121 118 143 74 80
Investments 0 0 2,761 2,937 2,907 2,900 2,882 3,032 2,913 2,848 2,850
12 12 808 969 1,124 1,113 1,039 708 743 739 790
Total Assets 12 12 5,537 5,807 5,816 5,735 5,552 5,214 5,181 5,077 5,108

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-1 3 270 20 120 197 -2 227 -53 24
0 0 -16 -175 -24 -74 62 -173 41 97
1 -2 -225 142 -85 -124 -71 -46 1 -131
Net Cash Flow -0 1 29 -12 10 -2 -10 9 -11 -10

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 0 58 108 86 91 217 78 133 205
Inventory Days 390 397 500 390 690 723 389 534
Days Payable 149 207 210 157 204 198 182 365
Cash Conversion Cycle 0 298 298 376 324 703 604 340 374
Working Capital Days 467 278 288 284 230 785 362 267 351
ROCE % 21% 3% 2% 2% 2% -2% -1% -1% -1%

Shareholding Pattern

Numbers in percentages

4 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
59.32% 59.32% 59.32% 59.32% 59.32% 59.32% 59.32% 59.32% 59.32% 59.32% 59.32% 59.32%
4.60% 5.50% 5.85% 6.20% 7.20% 9.34% 8.90% 8.80% 8.60% 8.70% 8.05% 8.18%
6.31% 6.91% 6.63% 4.26% 3.86% 2.55% 3.13% 3.51% 3.68% 2.36% 1.47% 1.22%
29.77% 28.26% 28.19% 30.22% 29.61% 28.79% 28.65% 28.37% 28.39% 29.63% 31.17% 31.29%
No. of Shareholders 54,66256,32256,98659,65461,17556,58356,22156,27252,33650,65653,68355,280

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls